The combination of two methods, MSP and qMSP, within the homogenous cohort (IDH1/2wt patients older than 50 years and with surgically resected glioma) gave significant relevance to the prognostic value of the MGMT promoter methylation status in Serbian diffuse glioma patients. The gene discussed is IDH1; the disease is central nervous system cancer.